Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Biotech
Ampio prepares to wind down after final therapeutic dream dies
With its sole remaining asset having failed to even enter the clinic, Ampio Pharmaceuticals has decided to call it a day.
James Waldron
Mar 26, 2024 9:01am
Innate drops monotherapy plans for lacutamab in type of lymphoma
Mar 21, 2024 8:27am
Phase 2 fail sends OcuTerra's eye drop dreams down the drain
Mar 14, 2024 9:15am
Spruce lays off 5th of staff in wake of phase 2 hyperplasia fail
Mar 14, 2024 8:27am
Acelyrin rebounds with psoriatic arthritis victory
Mar 11, 2024 10:59am
AbbVie drops MacroGenics-partnered ADC in light of early data
Mar 8, 2024 8:20am